Literature DB >> 27003768

Determinants of liver disease progression in children with chronic hepatitis C virus infection.

Maria Pokorska-Śpiewak1, Barbara Kowalik-Mikołajewska, Małgorzata Aniszewska, Magdalena Pluta, Bożena Walewska-Zielecka, Magdalena Marczyńska.   

Abstract

Histopathological features and determinants of liver disease progression were analyzed in 42 treatment-naïve children (mean age: 10.7 ±3.7) with chronic hepatitis C (14/42 infected vertically and 26/42 horizontally). Histopathological evaluation was performed according to Knodell's modified system. Predictors of necroinflammation and fibrosis were identified using linear regression analyses. Most children presented with mild necroinflammation and fibrosis (mean grade 4.3 ±2.7, mean staging 1.2 ±0.8), irrespective of the mode of transmission. Vertically infected children were younger than those infected horizontally (8.6 ±2.5 vs. 11.5 ±3.7 years, p = 0.02). Alanine and aspartate aminotransferase (ALT and AST) levels were associated with necroinflammation (p = 0.003 and p = 0.01 for ALT and AST, respectively) and fibrosis (p = 0.01 and p = 0.04, respectively). Other positive independent predictors of fibrosis included duration of infection (p = 0.03) and body mass index (BMI) z-score (p = 0.03). Children with chronic hepatitis C presented with mild liver changes over a decade after the infection, irrespective of the mode of transmission. Since fibrosis is a time-dependent process, progression of the liver disease in vertically infected children may occur at a younger age compared to patients infected horizontally. Aminotransferase levels were associated with necroinflammation and fibrosis. Longer duration of infection and a higher BMI z-score were associated with more severe fibrosis.

Entities:  

Mesh:

Year:  2015        PMID: 27003768     DOI: 10.5114/pjp.2015.57248

Source DB:  PubMed          Journal:  Pol J Pathol        ISSN: 1233-9687            Impact factor:   1.072


  4 in total

1.  Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C.

Authors:  Maria Pokorska-Śpiewak; Barbara Kowalik-Mikołajewska; Małgorzata Aniszewska; Magdalena Pluta; Magdalena Marczyńska
Journal:  BMC Infect Dis       Date:  2017-05-23       Impact factor: 3.090

2.  One-Year Outcomes after Ledipasvir/Sofosbuvir Treatment of Chronic Hepatitis C in Teenagers with and without Significant Liver Fibrosis-A Case Series Report.

Authors:  Maria Pokorska-Śpiewak; Anna Dobrzeniecka; Magdalena Marczyńska
Journal:  Viruses       Date:  2021-07-31       Impact factor: 5.048

Review 3.  Management of hepatitis C in children and adolescents during COVID-19 pandemic.

Authors:  Maria Pokorska-Śpiewak; Mateusz Śpiewak
Journal:  World J Hepatol       Date:  2020-08-27

4.  The Influence of Treatment with Ledipasvir/Sofosbuvir on Growth Parameters in Children and Adolescents with Chronic Hepatitis C.

Authors:  Maria Pokorska-Śpiewak; Anna Dobrzeniecka; Magdalena Marczyńska
Journal:  Viruses       Date:  2022-02-25       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.